Rishad Sayedmuhammed Kalappurakkal

Rishad Sayedmuhammed Kalappurakkal

Active Director Director DIN 07920393
DIN 07920393 First appointment Sep 2017 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Total affiliations 3 Since Sep 2017
Shareholding value •••• Premium profile

About Rishad Sayedmuhammed Kalappurakkal

Data last updated:

Rishad Sayedmuhammed Kalappurakkal is a Director at Zygene Biotechnologies Private Limited (since 2019), Director at Klonos Life Sciences Private Limited (since 2017) and Director at Biomend Lifesciences Private Limited (since 2025). The companies operate in Life Sciences, Research & Development and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹7.7 Lakh; the largest is Zygene Biotechnologies Private Limited at ₹7.3 Lakh (FY 2024).

DIN 07920393
Primary Designation Director
Industry Life Sciences
First Appointment 14 Sep 2017
Oldest Company Age 9 yrs
Largest company Zygene Biotechnologies Private Limited · ₹7.3 Lakh (FY 2024)
Combined revenue ₹7.7 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Jun 20192019₹7.3 Lakh (FY 2024)Active
Klonos Life Sciences Private Limited U73200KL2017PTC050418
Director14 Sep 20172017₹33,733 (FY 2022)Active
Biomend Lifesciences Private Limited U72100KL2025PTC094272
Director07 May 20252025Active

Board colleagues of Rishad Sayedmuhammed Kalappurakkal

Directorship timeline

Open interactive timeline →
Klonos Life Sciences Private Limited
Zygene Biotechnologies Private Limited
Biomend Lifesciences Private Limited
Premium access

Shareholding and investment profile for Rishad Sayedmuhammed Kalappurakkal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rishad Sayedmuhammed Kalappurakkal

Rishad Sayedmuhammed Kalappurakkal currently holds 3 directorships: Zygene Biotechnologies Private Limited (Director, since 24 Jun 2019, revenue ₹7.3 Lakh (FY 2024)); Klonos Life Sciences Private Limited (Director, since 14 Sep 2017, revenue ₹33,733 (FY 2022)); Biomend Lifesciences Private Limited (Director, since 07 May 2025).

Rishad Sayedmuhammed Kalappurakkal was first appointed on 14 Sep 2017 as Director at Klonos Life Sciences Private Limited. The most recent appointment on record is 07 May 2025 at Biomend Lifesciences Private Limited.

The 2 current companies of Rishad Sayedmuhammed Kalappurakkal that report revenue have a combined latest revenue of ₹7.7 Lakh: Zygene Biotechnologies Private Limited ₹7.3 Lakh (FY 2024); Klonos Life Sciences Private Limited ₹33,733 (FY 2022).

The current boards of Rishad Sayedmuhammed Kalappurakkal's companies include Nasiya Kalappurakal Aliyar (Zygene Biotechnologies Private Limited), Bineesh Skaria (Klonos Life Sciences Private Limited), Firoz A (Biomend Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available